<\/p>\n
Apidra SoloStar<\/strong> is a pre-filled disposable insulin pen containing insulin glulisine<\/strong> (100 units\/mL, 3 mL pen) — a rapid-acting insulin analogue<\/strong> used at meal-times (bolus insulin) in type 1 and type 2 diabetes. It has an onset of 10–15 minutes, peak effect at 1–2 hours, and total duration of 3–5 hours. Inject subcutaneously into the abdomen, thigh, or upper arm 5–15 minutes before a meal (or immediately after for unpredictable eaters). Usual dose: 0.5–1 unit per 10 g of carbohydrate, individualised to glucose, carb intake, and insulin sensitivity. Main risk: hypoglycaemia.<\/strong> Pair with a basal (long-acting) insulin in type 1 diabetes, or use alongside oral agents or basal insulin in type 2. Store unopened pens at 2–8°C; once in use, keep at room temperature < 30°C for up to 28 days.<\/p>\n<\/div>\n \ud83d\udce6 Hver ordre er dekket av v\u00e5r Reshipment Assurance Policy<\/strong><\/a> \u2014 hvis pakken din ikke ankommer innen 20 virkedager, sender vi ny.<\/p>\n V\u00e5re generiske legemidler kommer fra WHO-GMP-sertifiserte produsenter og sendes over hele verden i diskret, n\u00f8ytral emballasje \u2014 ingen legemiddelnavn p\u00e5 utsiden av pakken. Kortbetalinger h\u00e5ndteres av en regulert betalingsbehandler (kontoutskrifter viser en regulert kortbetalingsprosessor \u2014 aldri \u201cMedsBase\u201d eller noe legemiddelnavn). Krypto og SEPA bankoverf\u00f8rsel godtas ogs\u00e5. Hver ordre er dekket av v\u00e5r Reshipment Assurance Policy.<\/p>\n Apidra SoloStar is a pre-filled disposable pen containing 3 mL (300 units) of insulin glulisine, dialing 1–80 units per dose in 1-unit increments. It contains insulin glulisine (100 units\/mL, 3 mL pen) manufactured by Sanofi, supplied in packs of 1 or 5 pre-filled pens.<\/p>\n insulin glulisine is a rapid-acting insulin analogue<\/strong> — a meal-time (“bolus”) insulin used to match the post-meal glucose rise. Apidra is the originator brand worldwide.<\/p>\n Insulin is the natural hormone the pancreas releases after meals to help cells absorb glucose. In diabetes, this insulin response is either absent (type 1) or insufficient (type 2). Meal-time insulin injections replace that response.<\/p>\n Insulin glulisine has asparagine at position B3 replaced with lysine, and lysine at position B29 replaced with glutamic acid — this keeps the insulin monomeric in solution (without relying on zinc) and gives the fastest onset of the rapid-acting analogues. This gives a pharmacokinetic profile tailored to the meal-time glucose rise:<\/p>\n This profile closely mimics physiological post-meal insulin release — much better than regular human insulin, which has a slow 30-minute onset and a long 6–8 hour tail that can cause late hypoglycaemia.<\/p>\n Tidspunkt:<\/strong> inject 5–15 minutes before each meal. If meal timing is unpredictable (young children, unwell adults), injecting just before or even immediately after the meal is acceptable — this flexibility is a key advantage of rapid-acting analogues over regular insulin.<\/p>\n Dose:<\/strong> individualised to the patient. Common starting approaches:<\/p>\n Injection technique:<\/strong><\/p>\n Most important:<\/strong><\/p>\n Lokalt:<\/strong><\/p>\n Sjeldne, men viktige:<\/strong><\/p>\n \u00d8ker risiko for hypoglykemi:<\/strong> sulfonylureas, meglitinides, ACE inhibitors, disopyramide, fibrates, fluoxetine, MAOIs, pentoxifylline, propoxyphene, salicylates, sulfonamide antibiotics, somatostatin analogues, alcohol.<\/p>\n Reduce insulin effect:<\/strong> corticosteroids, oral contraceptives, thiazides, thyroid hormones, sympathomimetics, atypical antipsychotics, isoniazid, niacin, danazol, protease inhibitors.<\/p>\n Variable:<\/strong> beta-blockers (mask hypoglycaemia symptoms), lithium, octreotide.<\/p>\n In pregnancy:<\/strong> rapid-acting analogues are considered compatible and widely used. Discuss with your obstetric diabetes team.<\/p>\n Paediatric use:<\/strong> both NovoRapid and Apidra are approved for use in children (Apidra from 4 years, NovoRapid from 1 year) with appropriate paediatric dosing.<\/p>\n Apidra (insulin glulisine), NovoRapid (aspart) and Humalog (lispro) are the three rapid-acting insulin analogues. They all have similar onset (10–15 minutes), peak (1–2 hours), and duration (3–5 hours). Clinical effects and side-effect profiles are essentially interchangeable. Choice is usually driven by formulary availability, pen device preference, and cost.<\/p>\n 5–15 minutes before the meal is standard and gives the best glucose control. Injecting just before or immediately after is acceptable when meal timing is unpredictable — for young children, people with gastroparesis, or when you do not yet know how much you will eat. Injecting much later than that reduces control of the post-meal spike.<\/p>\n Eat a fast-acting carbohydrate immediately (15 g of glucose), then a slower-acting snack (bread, biscuits, sandwich) to cover the ongoing insulin action over the next 3–5 hours. Check glucose every 15–30 minutes. Severe or unresponsive hypoglycaemia needs glucagon or medical help.<\/p>\n In type 1 diabetes — yes, always. Rapid-acting insulin alone cannot provide 24-hour basal coverage, and stopping long-acting insulin in type 1 diabetes causes diabetic ketoacidosis within hours. In type 2 diabetes, Apidra SoloStar is often used alongside basal insulin (glargine, degludec) and oral agents.<\/p>\n No — rapid-acting analogues should not be mixed with long-acting analogues (glargine, degludec, detemir) in the same syringe. Use separate injections. You can give them at the same time with different pens.<\/p>\n Yes — rapid-acting analogues including aspart and glulisine are the standard insulins for continuous subcutaneous insulin infusion (CSII) pumps. Ask your diabetes team for pump-specific guidance.<\/p>\n Yes — once you take the first injection, the pen lasts 28 days at room temperature (below 30°C). Discard on day 29 even if insulin remains. Note the start date on the pen.<\/p>\n You can order Apidra SoloStar (100 units\/mL, 3 mL pen) from MedsBase in packs of 1 or 5 pre-filled pens. Insulin ships with temperature-protected packaging; worldwide shipping. Discreet packaging and genuine Sanofi manufacturer stock.<\/p>\n <\/p>\n Andre produkter innen Kroniske tilstander<\/strong> som kunder ogs\u00e5 ser p\u00e5:<\/p>\n \u2705 Rapid glucose control Apidra Solostar pen contains Insulin.<\/p>","protected":false},"featured_media":57650,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3141,3223,3230,3231],"product_tag":[4342,4343],"class_list":{"0":"post-57649","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-category-overview","7":"product_cat-chronic-conditions","8":"product_cat-diabetes","9":"product_cat-diabetes-medication","10":"product_tag-apidra-solostar","11":"product_tag-insulin","13":"first","14":"instock","15":"shipping-taxable","16":"purchasable","17":"product-type-variable","18":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/nb\/wp-json\/wp\/v2\/product\/57649","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/nb\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/nb\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/nb\/wp-json\/wp\/v2\/comments?post=57649"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/nb\/wp-json\/wp\/v2\/media\/57650"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/nb\/wp-json\/wp\/v2\/media?parent=57649"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/nb\/wp-json\/wp\/v2\/product_brand?post=57649"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/nb\/wp-json\/wp\/v2\/product_cat?post=57649"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/nb\/wp-json\/wp\/v2\/product_tag?post=57649"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}Hvorfor bestille fra MedsBase<\/h3>\n
What Is Apidra SoloStar?<\/h2>\n
How Does Apidra SoloStar Work?<\/h2>\n
\n
Dosering og administrering<\/h2>\n
\n
\n
Bivirkninger<\/h2>\n
\n
\n
\n
Legemiddelinteraksjoner<\/h2>\n
Who Should Not Use Apidra SoloStar?<\/h2>\n
\n
Storage and Handling<\/h2>\n
\n
Vanlige sp\u00f8rsm\u00e5l<\/h2>\n
How does Apidra compare to NovoRapid or Humalog?<\/h3>\n
When should I inject Apidra SoloStar — before or after the meal?<\/h3>\n
What if I accidentally inject too much?<\/h3>\n
Do I need basal (long-acting) insulin too?<\/h3>\n
Can I mix Apidra SoloStar with long-acting insulin in the same syringe?<\/h3>\n
Can Apidra SoloStar be used in insulin pumps?<\/h3>\n
Does Apidra SoloStar expire once the pen is in use?<\/h3>\n
Where can I buy Apidra SoloStar online?<\/h3>\n
Relaterte diabetesmedikamenter<\/h2>\n
\n
Relaterte alternativer<\/h3>\n
\n
\n\u2705 Convenient pen format
\n\u2705 Adjustable dosing
\n\u2705 Lower hypoglycemia risk
\n\u2705 Easy self-administration<\/p>\n